-
1دورية أكاديمية
المؤلفون: Balázs Jóri, Stefanie Schatz, Len Kaller, Bettina Kah, Julia Roeper, Hayat O. Ramdani, Linda Diehl, Petra Hoffknecht, Christian Grohé, Frank Griesinger, Markus Tiemann, Lukas C. Heukamp, Markus Falk
المصدر: Cancers, Vol 13, Iss 12, p 2861 (2021)
مصطلحات موضوعية: liquid biopsy, lung cancer, routine diagnostics, osimertinib resistance, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Stefanie Schatz, Markus Falk, Balázs Jóri, Hayat O. Ramdani, Stefanie Schmidt, Eva-Maria Willing, Roopika Menon, Harry J. M. Groen, Linda Diehl, Matthias Kröger, Claas Wesseler, Frank Griesinger, Petra Hoffknecht, Markus Tiemann, Lukas C. Heukamp
المصدر: Cancers, Vol 12, Iss 6, p 1685 (2020)
مصطلحات موضوعية: immuno-oncology, tumor mutational burden, lung cancer, routine diagnostics, driver mutation, PD-L1, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3
المؤلفون: Linda Diehl, Balázs Jóri, Petra Hoffknecht, H. Ramdani, Len Kaller, Frank Griesinger, S. Schatz, Lukas C. Heukamp, Bettina Kah, Christian Grohé, Markus Tiemann, Markus Falk, J. Roeper
المصدر: Cancers
Volume 13
Issue 12
Cancers, Vol 13, Iss 2861, p 2861 (2021)مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_treatment, Article, 03 medical and health sciences, 0302 clinical medicine, Second line, Tki resistance, Medicine, Osimertinib, Liquid biopsy, Lung cancer, osimertinib resistance, RC254-282, liquid biopsy, business.industry, Hybrid capture, Disease progression, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, routine diagnostics, respiratory tract diseases, lung cancer, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Cancer research, business, Adjuvant
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b652b9684fd65dc190c6bb81d2a1f57eTest
-
4
المؤلفون: Wolfgang M. Brueckl, Gunther H. Wiest, C. Wesseler, Amanda Tufman, Petra Hoffknecht, Eckart Laack, Martin Reck, Jens Kollmeier, Achim Rittmeyer, Fabian Reich, Petros Christopoulos, Bernhard Ulm, Joachim H. Ficker, Albrecht Stenzinger
المصدر: Transl Lung Cancer Res
مصطلحات موضوعية: Oncology, Chemotherapy, medicine.medical_specialty, business.industry, medicine.medical_treatment, non-small cell lung cancer (NSCLC), medicine.disease, medicine.disease_cause, Angiogenesis inhibitor, Ramucirumab, Docetaxel, Internal medicine, medicine, Clinical endpoint, Original Article, KRAS, Lung cancer, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfd62c1af1271976de9c7e7002f9b7d5Test
https://pubmed.ncbi.nlm.nih.gov/34430350Test -
5
المؤلفون: Stephanie Dille, A. Fleitz, Jacqueline Rauh, Lukas C. Heukamp, Marlen Sandberg, Tobias Dechow, Albrecht Stenzinger, Frank Griesinger, Mike Thomas, Konrad Kokowski, Matthias Groschek, Wilko Weichert, Wolfgang Schütte, Wilfried Eberhardt, Jürgen Alt, Reinhard Büttner, Stefan Zacharias, Martin Sebastian, Martina Jänicke, Eyck von der Heyde, Thomas Wehler, A. Hipper, Petra Hoffknecht, Martin Metzenmacher
مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Medizin, medicine.disease_cause, Proto-Oncogene Proteins p21(ras), 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, Germany, Medicine, Humans, Prospective Studies, Registries, Lung cancer, neoplasms, business.industry, Standard treatment, medicine.disease, ddc, respiratory tract diseases, 030104 developmental biology, 030220 oncology & carcinogenesis, Trk receptor, Cohort, Mutation, Population study, Observational study, KRAS, business, Cohort study
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99033094ddf7a1abf8a1507bdf20369eTest
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85100908806Test -
6
المؤلفون: Wolfgang M. Brückl, Felix Steger, Jürgen Alt, M. Faehling, Philipp Schütt, Petra Hoffknecht, Anke Schlenska-Lange, Marlitt Horn, Daniel C. Christoph, Christian Schumann, Petros Christopoulos, Stephan Eisenmann
المصدر: Data in Brief
Data in Brief, Vol 34, Iss, Pp 106556-(2021)مصطلحات موضوعية: Oncology, PD-L1, medicine.medical_specialty, Durvalumab, Survival, medicine.medical_treatment, Population, Locally advanced, lcsh:Computer applications to medicine. Medical informatics, NSCLC, 03 medical and health sciences, Oligometastatic, 0302 clinical medicine, Internal medicine, Checkpoint inhibitor, medicine, Stage (cooking), lcsh:Science (General), Lung cancer, education, Adverse effect, 030304 developmental biology, Data Article, 0303 health sciences, education.field_of_study, Chemotherapy, Multidisciplinary, business.industry, Real world, medicine.disease, lcsh:R858-859.7, business, 030217 neurology & neurosurgery, Chemoradiotherapy, lcsh:Q1-390, Autoimmune
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04c4cbcd89668e3c5008a02947ba41b8Test
http://europepmc.org/articles/PMC7750486Test -
7
المؤلفون: Lukas C. Heukamp, Balázs Jóri, S. Schatz, Eva-Maria Willing, Matthias Kröger, Harry J.M. Groen, Linda Diehl, Stefanie Schmidt, Markus Falk, Hayat Oum El Kheir Ramdani, Frank Griesinger, Markus Tiemann, C. Wesseler, Roopika Menon, Petra Hoffknecht
المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: Cancers, 12(6):1685, 1-14. MDPI AG
Cancers
Volume 12
Issue 6
Cancers, Vol 12, Iss 1685, p 1685 (2020)مصطلحات موضوعية: 0301 basic medicine, Oncology, PD-L1, Cancer Research, medicine.medical_specialty, tumor mutational burden, BLOCKADE, NEOANTIGENS, PHASE-1, medicine.disease_cause, lcsh:RC254-282, Article, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, IMMUNOHISTOCHEMISTRY, Lung cancer, immuno-oncology, Mutation, biology, business.industry, driver mutation, Routine laboratory, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, routine diagnostics, OPEN-LABEL, EFFICACY, Immune checkpoint, respiratory tract diseases, lung cancer, 1ST-LINE TREATMENT, 030104 developmental biology, 030220 oncology & carcinogenesis, biology.protein, NIVOLUMAB PLUS IPILIMUMAB, Biomarker (medicine), Non small cell, Antibody, SENSITIVITY, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c8ac4497f7a0a8ca98d267c72164bc1Test
https://research.rug.nl/en/publications/3f08a1fc-fe7c-4f77-9a0f-80bf8ce9b9c8Test -
8
المؤلفون: Michael Thomas, Frank Griesinger, A. Hipper, Martina Jänicke, Martin Sebastian, Wilko Weichert, J. Sahlmann, A. Karatas, Christoph Maintz, A. Fleitz, Wilfried Eberhardt, Petra Hoffknecht, C. Losem, L. Spring, Norbert Marschner, Christian Grah, C. Bernhardt, Achim Rittmeyer
المصدر: 61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V..
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Medizin, Stock options, Subject (documents), Hematology, medicine.disease, Real life data, Outcome (game theory), language.human_language, Management, German, Internal medicine, Trk receptor, medicine, language, In patient, Pd l1 expression, Non small cell, Lung cancer, business, Routine care
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96bdeeb77e58efbada590e87616332b3Test
https://doi.org/10.1055/s-0039-3403351Test -
9
المؤلفون: Bernhard Ulm, Achim Rittmeyer, Fabian Reich, Petra Hoffknecht, Amanda Tufman, Jens Kollmeier, Petros Christopoulos, Joachim H. Ficker, Eckart Laack, Martin Reck, Gunther H. Wiest, C. Wesseler, Wolfgang M. Brueckl
المصدر: Clinical Medicine Insights: Oncology, Vol 14 (2020)
Clinical Medicine Insights. Oncologyمصطلحات موضوعية: Oncology, medicine.medical_specialty, ramucirumab, medicine.medical_treatment, Immune checkpoint inhibitors, immune checkpoint inhibitor, lcsh:RC254-282, Ramucirumab, 03 medical and health sciences, 0302 clinical medicine, Immune system, Internal medicine, medicine, In patient, 030212 general & internal medicine, Lung cancer, Chemotherapy, business.industry, palliative treatment, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Angiogenesis inhibitor, angiogenesis inhibitor, Docetaxel, 030220 oncology & carcinogenesis, Original Article, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7bff3f6b58dd61427a570a941728d11Test
https://doi.org/10.1177/1179554920951358Test -
10
المؤلفون: Norman Willich, Cornelia Dröge, Hans N. Macha, Wolfgang E. Berdel, K. Junker, Achim Heinecke, Michael Semik, Dorothea Riesenbeck, Petra Hoffknecht, Albert Linder, Michael Hamm, Michael Thomas, Cristina Sauerland, Lutz Freitag, Dieter Ukena, C. Rübe, Karl-Matthias Deppermann, Gerhard W. Sybrecht
المصدر: The Lancet Oncology. 9:636-648
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Antineoplastic Agents, Drug Administration Schedule, Pneumonectomy, chemistry.chemical_compound, medicine, Clinical endpoint, Humans, Stage (cooking), Lung cancer, Aged, Neoplasm Staging, business.industry, Carcinoma, Hazard ratio, Radiotherapy Dosage, Middle Aged, medicine.disease, Carboplatin, Surgery, Radiation therapy, Treatment Outcome, Oncology, chemistry, Chemotherapy, Adjuvant, Vindesine, Female, Radiotherapy, Adjuvant, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f4a3da517e769dcf90562937a3001d9Test
https://doi.org/10.1016/s1470-2045Test(08)70156-6